|
🐜
|
The effect of cardiac resynchronization on morbidity and mortality in heart failure.
7 auth.
J. Cleland,
J. Daubert,
E. Erdmann,
N. Freemantle,
D. Gras,
L. Kappenberger,
...
L. Tavazzi
|
12 |
2005 |
12
🐜
|
|
🐜
|
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.
19 auth.
K. Swedberg,
J. Cleland,
H. Dargie,
H. Drexler,
F. Follath,
M. Komajda,
L. Tavazzi,
O. Smiseth,
A. Gavazzi,
A. Haverich,
...
A. Hoes,
T. Jaarsma,
J. Korewicki,
Samuel Lévy,
C. Linde,
J. López-Sendón,
M. Nieminen,
L. Pierard,
W. Remme
|
12 |
2005 |
12
🐜
|
|
🐜
|
2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).
65 auth.
M. Brignole,
A. Auricchio,
G. Barón-Esquivias,
P. Bordachar,
G. Boriani,
O. Breithardt,
J. Cleland,
J. Deharo,
V. Delgado,
P. Elliott,
B. Gorenek,
C. Israel,
C. Leclercq,
C. Linde,
L. Mont,
...
L. Padeletti,
R. Sutton,
P. Vardas,
J. Zamorano,
S. Achenbach,
H. Baumgartner,
Jeroen J. Bax,
H. Bueno,
V. Dean,
C. Deaton,
Ç. Erol,
R. Fagard,
R. Ferrari,
D. Hasdai,
A. Hoes,
P. Kirchhof,
J. Knuuti,
P. Kolh,
P. Lancellotti,
A. Linhart,
P. Nihoyannopoulos,
M. Piepoli,
P. Ponikowski,
P. Sirnes,
J. Tamargo,
M. Tendera,
A. Torbicki,
W. Wijns,
S. Windecker,
C. Blomstrom-Lundqvist,
L. Badano,
Farid Aliyev,
D. Bänsch,
Walid Bsata,
P. Buser,
P. Charron,
J. Daubert,
D. Dobreanu,
S. Faerestrand,
J. Le Heuzey,
H. Mavrakis,
T. McDonagh,
J. Merino,
M. Nawar,
J. Nielsen,
B. Pieske,
L. Poposka,
F. Ruschitzka,
I. V. Van Gelder,
C. M. Wilson
|
11 |
2013 |
11
🐜
|
|
🐜
|
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial
11 auth.
F. Follath,
J. Cleland,
H. Just,
J. Papp,
H. Scholz,
K. Peuhkurinen,
...
V. Harjola,
V. Mitrović,
M. Abdalla,
E. Sandell,
L. Lehtonen
|
10 |
2002 |
10
🐜
|
|
🐜
|
State of the art: Using natriuretic peptide levels in clinical practice
26 auth.
A. Maisel,
C. Mueller,
K. Adams,
S. Anker,
N. Aspromonte,
J. Cleland,
A. Cohen-Solal,
U. Dahlstrom,
A. DeMaria,
S. Di Somma,
G. Filippatos,
G. Fonarow,
P. Jourdain,
M. Komajda,
Peter P. Liu,
...
T. McDonagh,
K. McDonald,
A. Mebazaa,
M. Nieminen,
W. Peacock,
M. Tubaro,
R. Valle,
M. Vanderhyden,
C. Yancy,
F. Zannad,
E. Braunwald
|
9 |
2008 |
9
🐜
|
|
🐜
|
Rosuvastatin in older patients with systolic heart failure.
28 auth.
J. Kjekshus,
E. Apetrei,
V. Barrios,
M. Böhm,
J. Cleland,
J. Cornel,
P. Dunselman,
C. Fonseca,
A. Goudev,
P. Grande,
L. Gullestad,
A. Hjalmarson,
J. Hradec,
A. Jánosi,
G. Kamenský,
...
M. Komajda,
J. Korewicki,
T. Kuusi,
F. Mach,
V. Mareev,
J. McMurray,
N. Ranjith,
M. Schaufelberger,
J. Vanhaecke,
D. V. van Veldhuisen,
F. Waagstein,
H. Wedel,
J. Wikstrand
|
9 |
2007 |
9
🐜
|
|
🦁
|
Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study.
J. Cleland,
A. Louis,
A. Rigby,
U. Janssens,
A. Balk
|
9 |
2005 |
9
🦁
|
|
🐬
|
Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis
R. Clark,
S. Inglis,
F. McAlister,
J. Cleland,
S. Stewart
|
9 |
2007 |
9
🐬
|
|
🐜
|
Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].
7 auth.
J. Cleland,
J. Daubert,
E. Erdmann,
N. Freemantle,
D. Gras,
L. Kappenberger,
...
L. Tavazzi
|
9 |
2006 |
9
🐜
|
|
🐜
|
Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.
8 auth.
K. Damman,
G. Navis,
A. Voors,
F. Asselbergs,
T. Smilde,
J. Cleland,
...
D. V. van Veldhuisen,
H. Hillege
|
9 |
2007 |
9
🐜
|
|
🐜
|
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations
18 auth.
C. Mueller,
K. McDonald,
R. de Boer,
A. Maisel,
J. Cleland,
N. Kozhuharov,
A. Coats,
M. Metra,
A. Mebazaa,
F. Ruschitzka,
...
M. Lainščak,
G. Filippatos,
P. Seferovic,
W. Meijers,
A. Bayés‐Genís,
T. Mueller,
M. Richards,
J. Januzzi
|
9 |
2019 |
9
🐜
|
|
🐜
|
Mitochondrial function as a therapeutic target in heart failure
16 auth.
David A. Brown,
Justin B. Perry,
Mitchell E. Allen,
H. Sabbah,
B. Stauffer,
S. Shaikh,
J. Cleland,
W. Colucci,
J. Butler,
A. Voors,
...
S. Anker,
B. Pitt,
B. Pieske,
G. Filippatos,
S. Greene,
M. Gheorghiade
|
9 |
2016 |
9
🐜
|
|
🦁
|
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
21 auth.
J. Cleland,
K. Bunting,
M. Flather,
D. Altman,
J. Holmes,
A. Coats,
L. Manzano,
J. McMurray,
F. Ruschitzka,
D. V. van Veldhuisen,
...
T. von Lueder,
M. Böhm,
B. Andersson,
J. Kjekshus,
M. Packer,
A. Rigby,
G. Rosano,
H. Wedel,
A. Hjalmarson,
J. Wikstrand,
D. Kotecha
|
8 |
2018 |
8
🦁
|
|
🐜
|
Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants
21 auth.
M. Mutambudzi,
Claire Niedwiedz,
E. Macdonald,
A. Leyland,
F. Mair,
Jana J. Anderson,
C. Celis-Morales,
J. Cleland,
J. Forbes,
J. Gill,
...
C. Hastie,
F. Ho,
B. Jani,
D. Mackay,
B. Nicholl,
C. O’Donnell,
N. Sattar,
P. Welsh,
J. Pell,
S. Katikireddi,
E. Demou
|
8 |
2020 |
8
🐜
|
